INND (Innerscope Hearing Technologies) Tariff Resilience Score: 0/10 (As of Jul. 07, 2026)


What is Innerscope Hearing Technologies Tariff Resilience Score?

Innerscope Hearing Technologies has the Tariff Resilience Score of 0, which implies that the company might have .

Innerscope Hearing Technologies has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Innerscope Hearing Technologies might have .


Innerscope Hearing Technologies  (OTCPK:INND) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Innerscope Hearing Technologies Tariff Resilience Score Related Terms


Innerscope Hearing Technologies Business Description

Address 2151 Professional Drive, Suite 105, Roseville, CA, USA, 95661
Innerscope Hearing Technologies Inc is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products (Hearing Products) dedicated to addressing the demand for affordable hearing solutions. The company operates retail hearing device clinics in California. InnerScope is focused on leveraging these strategic assets to identify, incubate, and support health-technology ventures positioned for growth in public markets and long-term shareholder value creation.